Literature DB >> 20204272

Promotion of melanoma growth by the metabolic hormone leptin.

Julie A Ellerhorst1, A H Diwan, Shyam M Dang, Deon G Uffort, Marilyn K Johnson, Carolyn P Cooke, Elizabeth A Grimm.   

Abstract

We have previously shown that melanoma cells proliferate in response to the metabolic hormones TRH and TSH. The objective of the present study was to test the hypothesis that a third metabolic hormone, leptin, serves as a growth factor for melanoma. Using western blotting, indirect immunofluorescence, and RT-PCR, leptin receptors were found to be expressed by human melanoma cells. In contrast, cultured melanocytes expressed message for the receptor without detectable protein. Melanoma cells responded to treatment with leptin by activating the MAPK pathway and proliferating. Melanoma cells but not melanocytes, also expressed leptin protein, creating a potential autocrine loop. Examination of human melanoma tumors by immunohistochemistry revealed that melanomas and nevi expressed leptin at a high frequency. Melanomas also strongly expressed the leptin receptor, whereas nevi expressed this receptor to a much lesser degree. We conclude that leptin is a melanoma growth factor and that a leptin autocrine-loop may contribute to the uncontrolled proliferation of these cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204272      PMCID: PMC3158136          DOI: 10.3892/or_00000713

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  25 in total

1.  Leptin induces nitric oxide synthase type II in C6 glioma cells. Role for nuclear factor-kappaB in hormone effect.

Authors:  Giuseppina Mattace Raso; Emanuela Esposito; Anna Iacono; Maria Pacilio; Anna Coppola; Giuseppe Bianco; Sabrina Diano; Raffaele Di Carlo; Rosaria Meli
Journal:  Neurosci Lett       Date:  2005-12-15       Impact factor: 3.046

2.  Pivotal role of nitric oxide in the control of blood pressure after leptin administration.

Authors:  G Frühbeck
Journal:  Diabetes       Date:  1999-04       Impact factor: 9.461

3.  Expression of thyrotropin-releasing hormone by human melanoma and nevi.

Authors:  Julie A Ellerhorst; Aresu A Naderi; Marilyn K Johnson; Pauline Pelletier; Victor G Prieto; A Hafeez Diwan; Marcella M Johnson; Debra C Gunn; Sandra Yekell; Elizabeth A Grimm
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

4.  Leptin mediates a proliferative response in human MCF7 breast cancer cells.

Authors:  Marie-Noelle Dieudonne; Florence Machinal-Quelin; Valérie Serazin-Leroy; Marie-Christine Leneveu; René Pecquery; Yves Giudicelli
Journal:  Biochem Biophys Res Commun       Date:  2002-04-26       Impact factor: 3.575

5.  Tumor iNOS predicts poor survival for stage III melanoma patients.

Authors:  Suhendan Ekmekcioglu; Julie A Ellerhorst; Victor G Prieto; Marcella M Johnson; Lyle D Broemeling; Elizabeth A Grimm
Journal:  Int J Cancer       Date:  2006-08-15       Impact factor: 7.396

6.  Leptin is a growth factor for colonic epithelial cells.

Authors:  J C Hardwick; G R Van Den Brink; G J Offerhaus; S J Van Deventer; M P Peppelenbosch
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

Review 7.  Intracellular signalling pathways activated by leptin.

Authors:  Gema Frühbeck
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

8.  Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli.

Authors:  Cecilia Garofalo; Mariusz Koda; Sandra Cascio; Mariola Sulkowska; Luiza Kanczuga-Koda; Jolanta Golaszewska; Antonio Russo; Stanislaw Sulkowski; Eva Surmacz
Journal:  Clin Cancer Res       Date:  2006-03-01       Impact factor: 12.531

9.  Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers.

Authors:  Françoise Révillion; Madia Charlier; Valérie Lhotellier; Louis Hornez; Sylvia Giard; Marie-Christine Baranzelli; Jean Djiane; Jean-Philippe Peyrat
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

Review 10.  Leptin: physiology and pathophysiology.

Authors:  G Frühbeck; S A Jebb; A M Prentice
Journal:  Clin Physiol       Date:  1998-09
View more
  18 in total

Review 1.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

Review 2.  Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Cezary Skobowiat; Blazej Zbytek; Radomir M Slominski; Jeffery D Steketee
Journal:  Adv Anat Embryol Cell Biol       Date:  2012       Impact factor: 1.231

Review 3.  Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer.

Authors:  K Karimi; T H Lindgren; C A Koch; Robert T Brodell
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

4.  Associations between benign cutaneous nevi and risk of Type 2 diabetes mellitus in men and women: results from two prospective cohort studies.

Authors:  H Dai; Q Sun; C Zhang; X Zhang; W-Q Li; J E Manson; F B Hu; Y Song
Journal:  Diabet Med       Date:  2016-12-29       Impact factor: 4.359

5.  Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins.

Authors:  Maomao Zhang; Julie S Di Martino; Robert L Bowman; Nathaniel R Campbell; Sanjeethan C Baksh; Theresa Simon-Vermot; Isabella S Kim; Pearce Haldeman; Chandrani Mondal; Vladimir Yong-Gonzales; Mohsen Abu-Akeel; Taha Merghoub; Drew R Jones; Xiphias Ge Zhu; Arshi Arora; Charlotte E Ariyan; Kivanç Birsoy; Jedd D Wolchok; Katherine S Panageas; Travis Hollmann; Jose Javier Bravo-Cordero; Richard M White
Journal:  Cancer Discov       Date:  2018-06-14       Impact factor: 39.397

6.  Immunohistochemical Expression of Leptin in Non Melanoma Skin Cancer.

Authors:  Azza G A Farag; Nada Farag Elnaidany; Marwa Mohammed Serag El-Dien
Journal:  J Clin Diagn Res       Date:  2016-08-01

7.  Expression of leptin and iNOS in oral melanomas in dogs.

Authors:  V R Greene; H Wilson; C Pfent; J Roethele; J Carwile; Y Qin; E Grimm; J A Ellerhorst
Journal:  J Vet Intern Med       Date:  2013-08-26       Impact factor: 3.333

8.  Subcutaneous adipocytes promote melanoma cell growth by activating the Akt signaling pathway: role of palmitic acid.

Authors:  Hiu Yee Kwan; Xiuqiong Fu; Bin Liu; Xiaojuan Chao; Chi Leung Chan; Huihui Cao; Tao Su; Anfernee Kai Wing Tse; Wang Fun Fong; Zhi-Ling Yu
Journal:  J Biol Chem       Date:  2014-09-16       Impact factor: 5.157

9.  A Comparison of B16 Melanoma Cells and 3T3 Fibroblasts Concerning Cell Viability and ROS Production in the Presence of Melatonin, Tested Over a Wide Range of Concentrations.

Authors:  Maria Angeles Bonmati-Carrion; Nuria Alvarez-Sánchez; Rüdiger Hardeland; Juan Antonio Madrid; Maria Angeles Rol
Journal:  Int J Mol Sci       Date:  2013-02-14       Impact factor: 5.923

10.  Melanoma in pregnancy: a case report and review of the literature.

Authors:  Dorota K Wielowieyska-Szybińska; Magdalena Spałkowska; Anna Wojas-Pelc
Journal:  Postepy Dermatol Alergol       Date:  2015-12-11       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.